127 related articles for article (PubMed ID: 7605198)
1. Analysis of target organs for the latency of murine cytomegalovirus DNA using specific pathogen free and germfree mice.
Matsuzawa H; Shimizu K; Okada K; Ando K; Hashimoto K; Koga Y
Arch Virol; 1995; 140(5):853-64. PubMed ID: 7605198
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide increases the amount of murine cytomegalovirus-DNA in mice latently infected with the virus.
Okada K; Tanaka K; Noda S; Okazaki M; Koga Y
Arch Virol; 1999; 144(12):2273-90. PubMed ID: 10664384
[TBL] [Abstract][Full Text] [Related]
3. Investigation of murine cytomegalovirus latency and reactivation in mice using viral mutants and the polymerase chain reaction.
Bevan IS; Sammons CC; Sweet C
J Med Virol; 1996 Apr; 48(4):308-20. PubMed ID: 8699162
[TBL] [Abstract][Full Text] [Related]
4. Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs.
Kurz S; Steffens HP; Mayer A; Harris JR; Reddehase MJ
J Virol; 1997 Apr; 71(4):2980-7. PubMed ID: 9060657
[TBL] [Abstract][Full Text] [Related]
5. The M33 chemokine receptor homolog of murine cytomegalovirus exhibits a differential tissue-specific role during in vivo replication and latency.
Cardin RD; Schaefer GC; Allen JR; Davis-Poynter NJ; Farrell HE
J Virol; 2009 Aug; 83(15):7590-601. PubMed ID: 19439478
[TBL] [Abstract][Full Text] [Related]
6. Role of the indigenous microbiota in maintaining the virus-specific CD8 memory T cells in the lung of mice infected with murine cytomegalovirus.
Tanaka K; Sawamura S; Satoh T; Kobayashi K; Noda S
J Immunol; 2007 Apr; 178(8):5209-16. PubMed ID: 17404304
[TBL] [Abstract][Full Text] [Related]
7. Treatment of murine cytomegalovirus salivary-gland infection by combined therapy with ganciclovir and thymic humoral factor gamma 2.
Palmon A; Blagerman S; Tel-Or S; Pecht M; Trainin N; Burstein Y; Rager-Zisman B
Antiviral Res; 1996 Dec; 33(1):55-64. PubMed ID: 8955853
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppression induces transcription of murine cytomegalovirus glycoprotein H in the eye and at non-ocular sites.
Duan Y; Atherton SS
Arch Virol; 1996; 141(3-4):411-23. PubMed ID: 8645084
[TBL] [Abstract][Full Text] [Related]
9. Potential Application of TALENs against Murine Cytomegalovirus Latent Infections.
Chen SJ; Chen YC
Viruses; 2019 May; 11(5):. PubMed ID: 31058862
[TBL] [Abstract][Full Text] [Related]
10. Mouse cytomegalovirus reactivation in severe combined immune deficient mice after implantation of latently infected salivary gland.
Schmader K; Henry SC; Rahija RJ; Yu Y; Daley GG; Hamilton JD
J Infect Dis; 1995 Aug; 172(2):531-4. PubMed ID: 7622898
[TBL] [Abstract][Full Text] [Related]
11. Latency, without persistence, of murine cytomegalovirus in the spleen and kidney.
Pollock JL; Virgin HW
J Virol; 1995 Mar; 69(3):1762-8. PubMed ID: 7853515
[TBL] [Abstract][Full Text] [Related]
12. Direct evidence using in situ polymerase chain reaction that the endothelial cell and T-lymphocyte harbor latent murine cytomegalovirus.
Koffron AJ; Mueller KH; Kaufman DB; Stuart FP; Patterson B; Abecassis MI
Scand J Infect Dis Suppl; 1995; 99():61-2. PubMed ID: 8668944
[TBL] [Abstract][Full Text] [Related]
13. Lungs are a major organ site of cytomegalovirus latency and recurrence.
Balthesen M; Messerle M; Reddehase MJ
J Virol; 1993 Sep; 67(9):5360-6. PubMed ID: 8394453
[TBL] [Abstract][Full Text] [Related]
14. The mouse cytomegalovirus immediate-early 1 gene is not required for establishment of latency or for reactivation in the lungs.
Busche A; Marquardt A; Bleich A; Ghazal P; Angulo A; Messerle M
J Virol; 2009 May; 83(9):4030-8. PubMed ID: 19211741
[TBL] [Abstract][Full Text] [Related]
15. Latent murine cytomegalovirus DNA in splenic stromal cells of mice.
Pomeroy C; Hilleren PJ; Jordan MC
J Virol; 1991 Jun; 65(6):3330-4. PubMed ID: 1851880
[TBL] [Abstract][Full Text] [Related]
16. Use of quantitative real-time PCR (qRT-PCR) to measure cytokine transcription and viral load in murine cytomegalovirus infection.
Tang-Feldman YJ; Wojtowicz A; Lochhead GR; Hale MA; Li Y; Pomeroy C
J Virol Methods; 2006 Feb; 131(2):122-9. PubMed ID: 16140399
[TBL] [Abstract][Full Text] [Related]
17. CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation.
Simon CO; Holtappels R; Tervo HM; Böhm V; Däubner T; Oehrlein-Karpi SA; Kühnapfel B; Renzaho A; Strand D; Podlech J; Reddehase MJ; Grzimek NK
J Virol; 2006 Nov; 80(21):10436-56. PubMed ID: 16928768
[TBL] [Abstract][Full Text] [Related]
18. Broncholaveolar lavage to detect cytomegalovirus infection, latency, and reactivation in immune competent hosts.
Mansfield S; Dwivedi V; Byrd S; Trgovcich J; Griessl M; Gutknecht M; Cook CH
J Med Virol; 2016 Aug; 88(8):1408-16. PubMed ID: 26762116
[TBL] [Abstract][Full Text] [Related]
19. Immunological responses in germfree mice infected with murine cytomegalovirus.
Tazume S; Umehara K; Leung WC; Ando K; Yoshida T; Hashimoto K
Tokai J Exp Clin Med; 1990 Mar; 15(1):13-20. PubMed ID: 1965064
[TBL] [Abstract][Full Text] [Related]
20. Persisting murine cytomegalovirus can reactivate and has unique transcriptional activity in ocular tissue.
Kercher L; Mitchell BM
J Virol; 2002 Sep; 76(18):9165-75. PubMed ID: 12186900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
